Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Telix Pharmaceuticals (TLX.AX) has a market cap of $5.54 billion USD. According to our data, Telix Pharmaceuticals is ranked No.2409 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $5.54 B |
6.01%
|
| Dec 31, 2024 | $5.23 B |
144.15%
|
| Dec 29, 2023 | $2.14 B |
38.65%
|
| Dec 30, 2022 | $1.54 B |
-6.19%
|
| Dec 31, 2021 | $1.65 B |
105.03%
|
| Dec 31, 2020 | $0.80 B |
143.87%
|
| Dec 31, 2019 | $0.33 B |
138.46%
|
| Dec 31, 2018 | $0.14 B |
4.84%
|
| Dec 29, 2017 | $0.13 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
| Market Cap | = | TLX.AX Stock Price | * | TLX.AX Shares Outstanding |
| = | $16.53 | * | 0.33 B | |
| = | $5.54 B |